treosulfan has been researched along with Immunologic Deficiency Syndromes in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carruthers, VA; Flood, T; Gennery, AR; Lum, SH; Slatter, MA | 1 |
| Bąbol-Pokora, K; Dąbrowska-Leonik, N; Frączkiewicz, J; Gul, K; Janeczko-Czarnecka, M; Kałwak, K; Martuszewski, A; Mielcarek-Siedziuk, M; Młynarski, W; Nowak, M; Paluszkiewicz, P; Salamonowicz-Bodzioch, M; Sierżęga-Staykov, K; Ussowicz, M; Wawrzyniak-Dzierżek, E; Wolska-Kuśnierz, B | 1 |
| Abd Hamid, IJ; Abinun, M; Amrolia, P; Cant, AJ; Chiesa, R; Elfeky, R; Flood, T; Gaspar, HB; Gennery, AR; Hambleton, S; Nademi, Z; Pearce, MS; Qasim, W; Rao, K; Slatter, MA; Veys, P; Worth, A | 1 |
| Altun, D; Doğu, EF; Haskoloğlu, Ş; İkincioğulları, A; İslamoğlu, C; Kendirli, T; Köstel Bal, S | 1 |
| Abinun, M; Amrolia, P; Cant, A; Davies, G; Flood, T; Gaspar, HB; Gennery, AR; Goulden, N; Hambleton, S; Nademi, Z; Qasim, W; Rao, K; Slatter, MA; Veys, P | 1 |
1 trial(s) available for treosulfan and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK Experience.
Topics: Adolescent; Adult; Alemtuzumab; Allografts; Busulfan; Child; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Infant; Male; Risk Factors; Survival Rate; Transplantation Conditioning; United Kingdom; Vidarabine | 2018 |
4 other study(ies) available for treosulfan and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Hematopoietic Cell Transplant for CD40 Ligand Deficiency-Comparing Busulfan Versus Treosulfan.
Topics: Antineoplastic Agents, Alkylating; Busulfan; CD40 Ligand; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Transplantation Conditioning | 2022 |
Successful Allogeneic Stem Cell Transplantation in Nuclear Factor-Kappa B Essential Modulator Deficiency Syndrome After Treosulfan-Based Conditioning: A Case Report.
Topics: Antilymphocyte Serum; Busulfan; Ectodermal Dysplasia; Hematopoietic Stem Cell Transplantation; Humans; I-kappa B Kinase; Immunologic Deficiency Syndromes; Infant; Male; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2020 |
Outcome of treosulfan-based reduced-toxicity conditioning regimens for HSCT in high-risk patients with primary immune deficiencies.
Topics: Adolescent; Busulfan; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Infant; Male; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 2018 |
Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Busulfan; Child; Child, Preschool; Chimerism; Cohort Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Infant; Survival Analysis; Transplantation Conditioning; United Kingdom | 2011 |